1-8 of 8
Austin I Kim, MD
Close
Sort by
Journal Articles

Updated Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab (AVO) for Frontline Treatment of Chronic Lymphocytic Leukemia (CLL)

Matthew S. Davids, MD, Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Jennifer L. Crombie, MD, Samuel Ng, MD PhD, Austin I. Kim, MD, Matthew Weinstock, MD, Jessica Lowney, Samantha Pazienza, Josie Montegaard, NP, Victoria Patterson, BSN, RN, Caron A. Jacobson, MD, Ann S. LaCasce, MD MSc, Philippe Armand, MD PhD, Jon E. Arnason, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-139864
Published: 2020
Journal Articles

Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy

Reid W Merryman, MD, Gabriela Spilberg, MD, Patrizia Mondello, MDPhDMSc, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Matthew Chase, MD, Gilles Salles, MDPhD, Andrew D Zelenetz, MD PhD, Jennifer R Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric D Jacobsen, MD, Caron A. Jacobson, MD, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Y. Ng, MDPhD, Oreofe Odejide, MD, Philippe Armand, MD PhD, Heather A. Jacene, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-135919
Published: 2020
Journal Articles

Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma

Reid W Merryman, MD, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Kristin M McHugh, Jennifer R. Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric Jacobsen, MD, Caron Jacobson, MD MMSc, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Ng, MD PhD, Oreofe O. Odejide, MDMPH, Parastoo B. Dahi, MD, Yago Nieto, MD, Robin M. Joyce, MD, Yi-Bin Chen, MD, Alex F. Herrera, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-140965
Published: 2020
Journal Articles

Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL/SLL or Richter's Syndrome

Jennifer L. Crombie, MD, Svitlana Tyekucheva, PhD, Zixu Wang, MS, Alexandra Savell, BS, Lisa Brennan, RN, BSN, Jessica Lowney, Karen Francoeur, RN, Josie Montegaard, NP, Austin I. Kim, MD, Jacob D. Soumerai, MD, Jon E. Arnason, MD, Allan Louie Cruz, MD, Sigrid Berg, MD, David C. Fisher, MD, Jennifer R Brown, MD PhD, Matthew S. Davids, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138811
Published: 2020
Journal Articles

Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Jennifer L. Crombie, MD, Austin I Kim, MD, Reid W Merryman, MD, Jessica Lowney, Josie Montegaard, NP, Victoria Patterson, RN, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Ann S. LaCasce, MD MMSc, Jon E. Arnason, MD, Philippe Armand, MD PhD, David C. Fisher, MD, Jennifer R. Brown, MD PhD, Matthew S. Davids, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 32.
https://doi.org/10.1182/blood-2019-127506
Published: 2019
Journal Articles

Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience

Reid W Merryman, MD, Brad S Kahl, MD, Robert A. Redd, MS, Jad Bsat, BA, Matthew Lewis Chase, Ann S. LaCasce, MD MSc, Arnold S. Freedman, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Jennifer L Crombie, MD, Austin I Kim, MD, Oreofe O. Odejide, MD, Matthew S. Davids, MD, Jennifer R. Brown, MD PhD, Heather A. Jacene, Mehta-Shah Neha, Natasha Edwin, MD, Amanda F Cashen, MD, Nancy L. Bartlett, MD, Armin Ghobadi, MD, Philippe Armand, MD PhD, Robin M. Joyce, MD, Eric D Jacobsen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 145.
https://doi.org/10.1182/blood-2018-99-110520
Published: 2018
Journal Articles

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, MD PhD, Yi-Bin Chen, MD, Robert A. Redd, MS, Robin M. Joyce, MD, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Mikel Lipschitz, M.S., Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Alex F Herrera, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2018-99-113685
Published: 2018
Journal Articles

PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation

Yi-Bin Chen, MD, Philippe Armand, MD PhD, Robert A. Redd, MS, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Alex F. Herrera, MD, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Robin M. Joyce, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 706.
https://doi.org/10.1182/blood-2018-99-114914
Published: 2018